MRI metadata, particularly free-text series descriptions (SDs) used to identify sequences, are highly heterogeneous due to variable inputs by manufacturers and technologists. This variability poses challenges in correctly identifying series for hanging protocols and dataset curation. The purpose of this study was to evaluate the ability of large language models (LLMs) to automatically classify MRI SDs. We analyzed non-contrast brain MRIs performed between 2016 and 2022 at our institution, identifying all unique SDs in the metadata. A practicing neuroradiologist manually classified the SD text into: "T1," "T2," "T2/FLAIR," "SWI," "DWI," ADC," or "Other." Then, various LLMs, including GPT 3.5 Turbo, GPT-4, GPT-4o, Llama 3 8b, and Llama 3 70b, were asked to classify each SD into one of the sequence categories. Model performances were compared to ground truth classification using area under the curve (AUC) as the primary metric. Additionally, GPT-4o was tasked with generating regular expression templates to match each category. In 2510 MRI brain examinations, there were 1395 unique SDs, with 727/1395 (52.1%) appearing only once, indicating high variability. GPT-4o demonstrated the highest performance, achieving an average AUC of 0.983 ± 0.020 for all series with detailed prompting. GPT models significantly outperformed Llama models, with smaller differences within the GPT family. Regular expression generation was inconsistent, demonstrating an average AUC of 0.774 ± 0.161 for all sequences. Our findings suggest that LLMs are effective for interpreting and standardizing heterogeneous MRI SDs.

Low-grade gliomas (LGGs) are among the most problematic brain tumors to reliably segment in FLAIR MRI, and effective delineation of these lesions is critical for clinical diagnosis, treatment planning, and patient monitoring. Nevertheless, conventional U-Net-based approaches usually suffer from the loss of critical structural details owing to repetitive down-sampling, while the encoder features often retain irrelevant information that is not properly utilized by the decoder. To solve these challenges, this paper offers a dual-attention U-shaped design, named ECASE-Unet, which seamlessly integrates Efficient Channel Attention (ECA) and Squeeze-and-Excitation (SE) blocks in both the encoder and decoder stages. By selectively recalibrating channel-wise information, the model increases diagnostically significant regions of interest and reduces noise. Furthermore, dilated convolutions are introduced at the bottleneck layer to capture multi-scale contextual cues without inflating computational complexity, and dropout regularization is systematically applied to prevent overfitting on heterogeneous data. Experimental results on the Kaggle Low-Grade-Glioma dataset suggest that ECASE-Unet greatly outperforms previous segmentation algorithms, reaching a Dice coefficient of 0.9197 and an Intersection over Union (IoU) of 0.8521. Comprehensive ablation studies further reveal that integrating ECA and SE modules delivers complementing benefits, supporting the model's robust efficacy in precisely identifying LGG boundaries. These findings underline the potential of ECASE-Unet to expedite clinical operations and improve patient outcomes. Future work will focus on improving the model's applicability to new MRI modalities and studying the integration of clinical characteristics for a more comprehensive characterization of brain tumors.

The aim of this study was to evaluate image quality for contrast-enhanced (CE) neck MRI with a deep learning-reconstructed VIBE sequence with acceleration factors (AF) 4 (DL4-VIBE) and 6 (DL6-VIBE). Patients referred for neck MRI were examined in a 3-Tesla scanner in this prospective, single-center study. Four CE fat-saturated (FS) VIBE sequences were acquired in each patient: Star-VIBE (4:01 min), VIBE (2:05 min), DL4-VIBE (0:24 min), DL6-VIBE (0:17 min). Image quality was evaluated by three radiologists with a 5-point Likert scale and included overall image quality, muscle contour delineation, conspicuity of mucosa and pharyngeal musculature, FS uniformity, and motion artifacts. Objective image quality was assessed with signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and quantification of metal artifacts. 68 patients (60.3% male; mean age 57.4±16 years) were included in this study. DL4-VIBE was superior for overall image quality, delineation of muscle contours, differentiation of mucosa and pharyngeal musculature, vascular delineation, and motion artifacts. Notably, DL4-VIBE exhibited exceptional FS uniformity (p<0.001). SNR and CNR were superior for DL4-VIBE compared to all other sequences (p<0.001). Metal artifacts were least pronounced in the standard VIBE, followed by DL4-VIBE (p<0.001). Although DL6-VIBE was inferior to DL4-VIBE, it demonstrated improved FS homogeneity, delineation of pharyngeal mucosa, and CNR compared to Star-VIBE and VIBE. DL4-VIBE significantly improves image quality for CE neck MRI with a fraction of the scan time of conventional sequences.

The present study performs a comprehensive fairness analysis of machine learning (ML) models for the diagnosis of Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD) from MRI-derived neuroimaging features. Biases associated with age, race, and gender in a multi-cohort dataset, as well as the influence of proxy features encoding these sensitive attributes, are investigated. The reliability of various fairness definitions and metrics in the identification of such biases is also assessed. Based on the most appropriate fairness measures, a comparative analysis of widely used pre-processing, in-processing, and post-processing bias mitigation strategies is performed. Moreover, a novel composite measure is introduced to quantify the trade-off between fairness and performance by considering the F1-score and the equalized odds ratio, making it appropriate for medical diagnostic applications. The obtained results reveal the existence of biases related to age and race, while no significant gender bias is observed. The deployed mitigation strategies yield varying improvements in terms of fairness across the different sensitive attributes and studied subproblems. For race and gender, Reject Option Classification improves equalized odds by 46% and 57%, respectively, and achieves harmonic mean scores of 0.75 and 0.80 in the MCI versus AD subproblem, whereas for age, in the same subproblem, adversarial debiasing yields the highest equalized odds improvement of 40% with a harmonic mean score of 0.69. Insights are provided into how variations in AD neuropathology and risk factors, associated with demographic characteristics, influence model fairness.

Fragile X Syndrome (FXS) is a rare neurodevelopmental disorder caused by a trinucleotide repeat expansion on the 5 untranslated region of the FMR1 gene. FXS is characterized by intellectual disability, anxiety, sensory hypersensitivity, and difficulties with executive function. A recent phase 2 placebo-controlled clinical trial assessing BPN14770, a first-in-class phosphodiesterase 4D allosteric inhibitor, in 30 adult males (age 18-41 years) with FXS demonstrated cognitive improvements on the NIH Toolbox Cognitive Battery in domains related to language and caregiver reports of improvement in both daily functioning and language. However, individual physiological measures from electroencephalography (EEG) demonstrated only marginal significance for trial efficacy. A secondary analysis of resting state EEG data collected as part of the phase 2 clinical trial evaluating BPN14770 was conducted using a machine learning classification algorithm to classify trial conditions (i.e., baseline, drug, placebo) via linear EEG variable combinations. The algorithm identified a composite of peak alpha frequencies (PAF) across multiple brain regions as a potential biomarker demonstrating BPN14770 efficacy. Increased PAF from baseline was associated with drug but not placebo. Given the relationship between PAF and cognitive function among typically developed adults and those with intellectual disability, as well as previously reported reductions in alpha frequency and power in FXS, PAF represents a potential physiological measure of BPN14770 efficacy.

Motion-related artifacts are inevitable in Magnetic Resonance Imaging (MRI) and can bias automated neuroanatomical metrics such as cortical thickness. Manual review cannot objectively quantify motion in anatomical scans, and existing automated approaches often require specialized hardware or rely on unbalanced noisy training data. Here, we train a 3D convolutional neural network to estimate motion severity using only synthetically corrupted volumes. We validate our method with one held-out site from our training cohort and with 14 fully independent datasets, including one with manual ratings, achieving a representative $R^2 = 0.65$ versus manual labels and significant thickness-motion correlations in 12/15 datasets. Furthermore, our predicted motion correlates with subject age in line with prior studies. Our approach generalizes across scanner brands and protocols, enabling objective, scalable motion assessment in structural MRI studies without prospective motion correction.

Menopausal hormone therapy (MHT) is generally thought to be neuroprotective, yet results have been inconsistent. Here, we present a comprehensive study of MHT use and brain characteristics in females from the UK Biobank. 19,846 females with magnetic resonance imaging data were included. Detailed MHT prescription data from primary care records was available for 538. We tested for associations between the brain measures (i.e. gray/white matter brain age, hippocampal volumes, white matter hyperintensity volumes) and MHT user status, age at first and last use, duration of use, formulation, route of administration, dosage, type, and active ingredient. We further tested for the effects of a history of hysterectomy ± bilateral oophorectomy among MHT users and examined associations by APOE ε4 status. Current MHT users, not past users, showed older gray and white matter brain age, with a difference of up to 9 mo, and smaller hippocampal volumes compared to never-users. Longer duration of use and older age at last use post-menopause was associated with older gray and white matter brain age, larger white matter hyperintensity volume, and smaller hippocampal volumes. MHT users with a history of hysterectomy ± bilateral oophorectomy showed <i>younger</i> gray matter brain age relative to MHT users without such history. We found no associations by APOE ε4 status and with other MHT variables. Our results indicate that population-level associations between MHT use and female brain health might vary depending on duration of use and past surgical history. The authors received funding from the Research Council of Norway (LTW: 223273, 249795, 273345, 298646, 300768), the South-Eastern Norway Regional Health Authority (CB: 2023037, 2022103; LTW: 2018076, 2019101), the European Research Council under the European Union's Horizon 2020 research and innovation program (LTW: 802998), the Swiss National Science Foundation (AMGdL: PZ00P3_193658), the Canadian Institutes for Health Research (LAMG: PJT-173554), the Treliving Family Chair in Women's Mental Health at the Centre for Addiction and Mental Health (LAMG), womenmind at the Centre for Addiction and Mental Health (LAMG, BHL), the Ann S. Bowers Women's Brain Health Initiative (EGJ), and the National Institutes of Health (EGJ: AG063843).

Medical image translation has become an essential tool in modern radiotherapy, providing complementary information for target delineation and dose calculation. However, current approaches are constrained by their modality-specific nature, requiring separate model training for each pair of imaging modalities. This limitation hinders the efficient deployment of comprehensive multimodal solutions in clinical practice. To develop a unified image translation method using variational autoencoder (VAE) latent space mapping, which enables flexible conversion between different medical imaging modalities to meet clinical demands. We propose a three-stage approach to construct a unified image translation model. Initially, a VAE is trained to learn a shared latent space for various medical images. A stacked bidirectional transformer is subsequently utilized to learn the mapping between different modalities within the latent space under the guidance of the image modality. Finally, the VAE decoder is fine-tuned to improve image quality. Our internal dataset collected paired imaging data from 87 head and neck cases, with each case containing cone beam computed tomography (CBCT), computed tomography (CT), MR T1c, and MR T2W images. The effectiveness of this strategy is quantitatively evaluated on our internal dataset and a public dataset by the mean absolute error (MAE), peak-signal-to-noise ratio (PSNR), and structural similarity index (SSIM). Additionally, the dosimetry characteristics of the synthetic CT images are evaluated, and subjective quality assessments of the synthetic MR images are conducted to determine their clinical value. The VAE with the Kullback‒Leibler (KL)-16 image tokenizer demonstrates superior image reconstruction ability, achieving a Fréchet inception distance (FID) of 4.84, a PSNR of 32.80 dB, and an SSIM of 92.33%. In synthetic CT tasks, the model shows greater accuracy in intramodality translations than in cross-modality translations, as evidenced by an MAE of 21.60 ± 8.80 Hounsfield unit (HU) in the CBCT-to-CT task and 45.23 ± 13.21 HU/47.55 ± 13.88 in the MR T1c/T2w-to-CT tasks. For the cross-contrast MR translation tasks, the results are very close, with mean PSNR and SSIM values of 26.33 ± 1.36 dB and 85.21% ± 2.21%, respectively, for the T1c-to-T2w translation and 26.03 ± 1.67 dB and 85.73% ± 2.66%, respectively, for the T2w-to-T1c translation. Dosimetric results indicate that all the gamma pass rates for synthetic CTs are higher than 99% for photon intensity-modulated radiation therapy (IMRT) planning. However, the subjective quality assessment scores for synthetic MR images are lower than those for real MR images. The proposed three-stage approach successfully develops a unified image translation model that can effectively handle a wide range of medical image translation tasks. This flexibility and effectiveness make it a valuable tool for clinical applications.

To investigate vessel delineation and image quality of ultra-high-resolution (UHR) CT angiography (CTA) reconstructed using deep learning reconstruction (DLR) optimised for brain CTA (DLR-brain) in moyamoya disease (MMD), compared with DLR optimised for body CT (DLR-body) and hybrid iterative reconstruction (Hybrid-IR). This retrospective study included 50 patients with suspected or diagnosed MMD who underwent UHR brain CTA. All images were reconstructed using DLR-brain, DLR-body, and Hybrid-IR. Quantitative analysis focussed on moyamoya perforator vessels in the basal ganglia and periventricular anastomosis. For these small vessels, edge sharpness, peak CT number, vessel contrast, full width at half maximum (FWHM), and image noise were measured and compared. Qualitative analysis was performed by visual assessment to compare vessel delineation and image quality. DLR-brain significantly improved edge sharpness, peak CT number, vessel contrast, and FWHM, and significantly reduced image noise compared with DLR-body and Hybrid-IR (P < 0.05). DLR-brain significantly outperformed the other algorithms in the visual assessment (P < 0.001). DLR-brain provided superior visualisation of small intracranial vessels compared with DLR-body and Hybrid-IR in UHR brain CTA.

Chemical Exchange Saturation Transfer (CEST) MRI has demonstrated its remarkable ability to enhance the detection of macromolecules and metabolites with low concentrations. While CEST mapping is essential for quantifying molecular information, conventional methods face critical limitations: model-based approaches are constrained by limited sensitivity and robustness depending heavily on parameter setups, while data-driven deep learning methods lack generalizability across heterogeneous datasets and acquisition protocols. To overcome these challenges, we propose a Lorentzian-model Informed Neural Representation (LINR) framework for high-quality CEST mapping. LINR employs a self-supervised neural architecture embedding the Lorentzian equation - the fundamental biophysical model of CEST signal evolution - to directly reconstruct high-sensitivity parameter maps from raw z-spectra, eliminating dependency on labeled training data. Convergence of the self-supervised training strategy is guaranteed theoretically, ensuring LINR's mathematical validity. The superior performance of LINR in capturing CEST contrasts is revealed through comprehensive evaluations based on synthetic phantoms and in-vivo experiments (including tumor and Alzheimer's disease models). The intuitive parameter-free design enables adaptive integration into diverse CEST imaging workflows, positioning LINR as a versatile tool for non-invasive molecular diagnostics and pathophysiological discovery.